The DURABLE Trial Study Design: Comparing the Safety, Efficacy, and Durability of Insulin Glargine to Insulin Lispro Mix 75/25 Added to Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes

Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis

Diabetes Therapy ◽

10.1007/s13300-020-00975-y ◽

2020 ◽

Author(s):

Dominik Lautsch ◽

Adnan Alsumali ◽

Euan McLeod ◽

Yuting Kuang ◽

Jing He ◽

...

Keyword(s):

Type 2 Diabetes ◽

Literature Review ◽

Systematic Literature Review ◽

Meta Analysis ◽

Comparative Efficacy ◽

Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroups

Diabetes Obesity and Metabolism ◽

10.1111/dom.13658 ◽

2019 ◽

Vol 21 (6) ◽

pp. 1340-1348 ◽

Cited By ~ 6

Author(s):

Martin Fuechtenbusch ◽

Jens Aberle ◽

Elke Heitmann ◽

Claudia Nicolay ◽

Heike Jung

Keyword(s):

Type 2 Diabetes ◽

Body Mass Index ◽

Weight Loss ◽

Insulin Glargine ◽

Body Mass ◽

Insulin Lispro ◽

Baseline Body Mass Index ◽

Post Hoc Analysis ◽

Post Hoc

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

The Lancet ◽

10.1016/s0140-6736(15)60936-9 ◽

2015 ◽

Vol 385 (9982) ◽

pp. 2057-2066 ◽

Cited By ~ 122

Author(s):

Lawrence Blonde ◽

Johan Jendle ◽

Jorge Gross ◽

Vincent Woo ◽

Honghua Jiang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Open Label ◽

Phase 3 ◽

Prandial Insulin ◽

Open Label Phase

Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus

Journal of Diabetes ◽

10.1111/1753-0407.12426 ◽

2016 ◽

Vol 9 (4) ◽

pp. 396-404 ◽

Cited By ~ 3

Author(s):

In-Kyung Jeong ◽

Choon Hee Chung ◽

Zhiguang Zhou ◽

Jeong Hee Han ◽

Ran Duan ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Lispro ◽

East Asian ◽

Once Daily ◽

Insulin Intensification ◽

Caucasian Patients

Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

Diabetes Care ◽

10.2337/dc14-0001 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2317-2325 ◽

Cited By ~ 143

Author(s):

Julio Rosenstock ◽

Vivian A. Fonseca ◽

Jorge L. Gross ◽

Robert E. Ratner ◽

Bo Ahrén ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Basal Insulin ◽

Receptor Agonist ◽

Prandial Insulin ◽

Oral Agents ◽

Insulin Replacement

Practical Review of Oral Antihyperglycemic Agents for Type 2 Diabetes Mellitus

The Diabetes Educator ◽

10.1177/0145721706294260 ◽

2006 ◽

Vol 32 (6) ◽

pp. 869-876 ◽

Cited By ~ 19

Author(s):

Renee Rae Koski

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

PDB69 OLDER PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES (T2DM) EXPERIENCE MORE DELAYED TREATMENT WITH ORAL ANTIHYPERGLYCEMIC AGENTS COMPARED WITH YOUNGER PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)72312-3 ◽

2010 ◽

Vol 13 (3) ◽

pp. A67

Author(s):

Q Zhang ◽

S Rajagopalan ◽

E Marrett ◽

L Radican

Keyword(s):

Type 2 Diabetes ◽

Older Patients ◽

Newly Diagnosed ◽

Younger Patients ◽

Delayed Treatment ◽

Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01257.x ◽

2010 ◽

Vol 12 (10) ◽

pp. 916-922 ◽

Cited By ~ 20

Author(s):

K. Strojek ◽

C. Shi ◽

M. A. Carey ◽

S. J. Jacober

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Lispro

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

Diabetes Care ◽

10.2337/dc08-2117 ◽

2009 ◽

Vol 32 (6) ◽

pp. 1007-1013 ◽

Cited By ~ 100

Author(s):

J. B. Buse ◽

B. H.R. Wolffenbuttel ◽

W. H. Herman ◽

N. K. Shemonsky ◽

H. H. Jiang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Safety And Efficacy ◽

Oral Antihyperglycemic Drugs

Premixed Insulin Lispro Versus Insulin Glargine In Type 2 Diabetes: A Meta-Analysis

Value in Health ◽

10.1016/j.jval.2014.08.141 ◽

2014 ◽

Vol 17 (7) ◽

pp. A741

Author(s):

Z Lili

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Meta Analysis ◽

Premixed Insulin